POLYGENETIC ABNORMALITIES IN JAPANESE PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

被引：0
|
作者：
Sekiguchi, Haruki
Koike, Toshiharu
Abe, Takuro
Sakai, Akiko
Sato, Kayoko
Hagiwara, Nobuhisa
机构：
[1] Tokyo Womens Med Univ, Inst Cardiol, Tokyo, Japan
[2] Natl Hosp Org, Yokohama Med Ctr, Yokohama, Kanagawa, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(18)32297-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1756
引用
收藏
页码：1756 / 1756
页数：1
相关论文
共 50 条
  • [21] ALPHALIPOPROTEINS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    MOORJANI, S
    GAGNE, C
    BRUN, LD
    TOUSSAINT, M
    LUPIEN, PJ
    UNION MEDICALE DU CANADA, 1980, 109 (04): : 530 - &
  • [22] GENETIC IDENTIFICATION OF HOMOZOGOUS FAMILIAL HYPERCHOLESTEROLEMIA AMONG PATIENTS WITH CLINICALLY DIAGNOSED HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Chaudhry, Ahsen
    Vesely, Kristin
    Trinder, Mark
    Brunham, Liam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1473 - 1473
  • [23] Patients' attitudes toward detection of heterozygous familial hypercholesterolemia
    Andersen, LK
    Jensen, HK
    Juul, S
    Faergeman, O
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (05) : 553 - 560
  • [24] Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia
    Reeskamp, Laurens F.
    Kastelein, John J. P.
    Moriarty, Patrick M.
    Duell, P. Barton
    Catapano, Alberico L.
    Santos, Raul D.
    Ballantyne, Christie M.
    ATHEROSCLEROSIS, 2019, 280 : 109 - 117
  • [25] Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
    Ershova, Alexandra I.
    Meshkov, Alexey N.
    Rozhkova, Tatyana A.
    Kalinina, Maria V.
    Deev, Alexander D.
    Rogoza, Anatoliy N.
    Balakhonova, Tatyana V.
    Boytsov, Sergey A.
    PLOS ONE, 2016, 11 (07):
  • [26] Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia
    Hartgers, Merel L.
    Defesche, Joep C.
    Langslet, Gisle
    Hopkins, Paul N.
    Kastelein, John J. P.
    Baccara-Dinet, Marie T.
    Seiz, Werner
    Hamon, Sara
    Banerjee, Poulabi
    Stefanutti, Claudia
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (02) : 390 - 396
  • [27] Aortic Valve Calcification and Coronary Plaque Morphology in Japanese Heterozygous Familial Hypercholesterolemia Patients With Gene Mutation
    Yamamoto, Aya
    Sakai, Akiko
    Sekiguchi, Haruki
    Sato, Kayoko
    Fukushima, Kenji
    Sakai, Syuji
    Hagiwara, Nobuhisa
    CIRCULATION, 2017, 136
  • [28] Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with heterozygous familial hypercholesterolemia
    Arai, Hidenori
    Teramoto, Tamio
    Daida, Hiroyuki
    Ikewaki, Katsunori
    Maeda, Yuko
    Nakagomi, Mariko
    Shirakawa, Masayoshi
    Kakikawa, Taro
    Numaguchi, Hirotaka
    Johnson-Levonas, Amy O.
    Vaidya, Sanskruti
    Blaustein, Robert O.
    ATHEROSCLEROSIS, 2016, 249 : 215 - 223
  • [29] Arterial characteristics in patients with heterozygous familial hypercholesterolemia: effect of rosuvastatin
    Masoura, C.
    Pitsavos, C.
    Skoumas, I.
    Aznaouridis, K.
    Vlachopoulos, C.
    Papadimitriou, L.
    Raftopoulou, S.
    Giotsas, N.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2008, 29 : 615 - 615
  • [30] Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
    Wozniak, Ewelina
    Broncel, Marlena
    Wozniak, Agnieszka
    Satala, Joanna
    Pawlos, Agnieszka
    Bukowska, Bozena
    Gorzelak-Pabis, Paulina
    SCIENTIFIC REPORTS, 2024, 14 (01)
12345